Billionaire Masayoshi Son, chairman and chief executive officer of SoftBank Group Corp., speaks in front of a screen displaying the ARM Holdings logo during a news conference in Tokyo on July 28, 2016.
Tomohiro Ohsumi | Bloomberg | Getty Images
Arm, which is owned by SoftBank, filed for its initial public offering Monday. The firm’s stock market debut will be a major test for the IPO market, which has more or less closed off from new listings due to rising interest rates which have hammered appetite for risky assets in the last year or so.
Arm is one of the most important companies in technology. Its chip designs found in nearly all the world’s smartphones, including Apple iPhones and most Android devices. Its debut will be a big deal for an IPO market that’s been in the doldrums since 2022, but the company’s listing has big implications for SoftBank as well.
SoftBank has been attempting to bounce back from a grim tech market by reining in on its growth-focused investments and pivoting its focus to artificial intelligence, the hot topic of the hour in tech.
What is Arm?
Arm, which is headquartered in Cambridge, England, designed the architecture of chips found in 99% of all smartphones.
The company traces its history to an early computing company known as Acorn Computers. In 1990, Acorn spun out a new company named Advanced RISC Machines, structured as a joint venture between Acorn, Apple and U.S. chipmaker VLSI Technology.
Arm isn’t a chipmaker itself. Rather, the company is responsible for coming up with the “architectures” — or overall designs, including components and programming language instructions that other companies use to build chips. Its original value was designing chips with extremely low energy consumption compared with the X86 chips common in personal computers at the time. It’s seen as something of a neutral party or “Switzerland” in tech, since its designs are used in nearly smartphone processors, including those made by Apple, and increasingly, server and laptop processors as well.
It’s also often considered the crown jewel of the U.K.’s technology sector.
Speaking with CNBC at a developer conference in October 2022, Arm CEO Rene Haas said that companies can’t afford not to work with the company, given its technology is embedded in virtually every device out there.
“Given the fact that we license the technology to all the major players in the industry, no one can really afford to miss a product cycle or scale back on R&D or not do a product,” Haas said at the time.
Arm’s business model is to license the intellectual property for these architectures so that they can build systems around them. In recent years, ARM has tried to sell its own designs for processors, a more lucrative business than just licensing the underlying architecture technology.
SoftBank agreed to acquire Arm in 2016 for $32 billion, which at the time was the biggest-ever purchase of a European technology company. SoftBank at the time said it was acquiring the business to gain a foothold in the growing internet of things sector. IoT, is a small part of the firm’s business, but at the time it was a much-hyped part of tech.
Not just for wearables or smart home appliances, Arm has been expanding its semiconductors to other uses such as connected cars.
For the quarter ended June 30, the company generated 88.5 billion Japanese yen ($605.5 million), according to an earnings release from SoftBank.
But the company is also facing headwinds from a slowdown in demand for products like smartphones, which has hit chip firms across the board. Arm’s net sales fell 4.6% year-on-year in the second quarter.
The unit also swung to a 9.5 billion yen loss, having made a profit of 29.8 billion yen in the same period a year earlier.
Beleaguered sale to Nvidia
SoftBank originally tried to sell Arm to chip giant Nvidia, but the deal faced pushback from regulators, who raised concerns over competition and national security. Nvidia is a behemoth in the world of semiconductors, and the company is now benefiting heavily from the boom in AI applications as demand for its GPUs soars.
Since then, SoftBank has opted to list Arm as an independent company. The Japanese tech investing giant is reportedly looking to purchase the remaining 25% stake in Arm that it does not currently own from its massive $100 billion Vision Fund.
In the U.K., which has sought to boost its domestic chip industry through up to £1 billion ($1.3 billion) in investments, Arm is seen as strategically important.
The change of the company’s ownership to foreign hands is seen as a thorny topic for the domestic tech industry, not least due to concerns that it undermines the U.K.’s “tech sovereignty,” an issue that has cropped up throughout Europe as officials look to reduce dependence on technology from the U.S. and other nations.
The government had pushed aggressively for Arm to list in London, however the company opted to go with New York for its debut instead, dealing a blow to the London stock exchange.
Testing a choppy IPO market
SoftBank is pushing ahead with a listing of Arm even as U.S. markets have been in an unsteady state. Technology valuations have fallen sharply from the peak of the 2021 tech boom.
That year, shares of newly minted public companies such as Palantir and UiPath rose to seismic levels as investors grew excited by their growth prospects in the boom times.
Arm filed confidentially for a listing in the U.S. earlier this year. It’s not yet clear what valuation SoftBank is seeking for Arm, however reports have pegged the prospective market value at between $60 billion and $70 billion.
As well as being a bellwether for the chip industry, Arm plays a role in the AI space — and is increasingly touting itself as an AI company. Investors will be watching out for the company’s S-1 filing to see how it sees the technology benefiting its business over time.
In May, Arm unveiled two new chipsets targeted at machine learning applications. One, a new CPU called Cortex-4, is a chipset that delivers faster machine-learning performance and consumes 40% less power than its predecessor, according to Arm. The other, a GPU called G720, offers better performance and uses up 22% less memory bandwidth than its predecessor, Arm said.
“Arm remains committed to developing and testing our GPUs against new applications for machine learning (ML),” the company said in a May 29 blog post announcing the products.
High-powered chips such as those offered by Nvidia and AMD are crucial to AI applications, which require lots of computing power to run smoothly. Earlier this month, Nvidia unveiled its new Grace Hopper chip for generative AI applications, which is based on Arm architecture.
SoftBank is banking on the growth in AI to lift the prospects of its Vision Fund, which has flagged in tandem with souring bets on firms like WeWork, China’s ride-hailing giant Didi Global, and Uber, the latter of which the Vision Fund has since shed its holdings.
SoftBank’s CFO Yoshimitsu Goto said during the company’s June quarter earnings call that the company has been “carefully and slowly emerging back to investment activity,” with a focus on AI investments.
SoftBank said its Vision Fund booked an investment gain of 159.8 billion yen, its first gain in five consecutive quarters. SoftBank said the fund mainly benefited from investments in its own subsidiaries — including Arm.
That still came after SoftBank’s Vision Fund reported a record 4.3 trillion yen loss in the fiscal year ending Mar. 31.
The Japanese tech giant has been starting to talk up its investments in AI recently. In July, the company led a $65 million investment in U.K. insurance technology company Tractable.
A logo hangs on the building of the Beijing branch of Semiconductor Manufacturing International Corporation (SMIC) on December 4, 2020 in Beijing, China.
After trading on Thursday, the company reported a first-quarter revenue of $2.24 billion, up about 28% from a year earlier. Meanwhile, profit attributable to shareholders surged 162% year on year to $188 million.
However, both figures missed LSEG mean estimates of $2.34 billion in revenue and $225.1 million in net income, as well as the company’s own forecasts.
During an earnings call Friday, an SMIC representative said the earnings missed original guidance due to“production fluctuations” which sent blended average selling prices falling. This impact is expected to extend into the second quarter, they added.
For the current quarter, the chipmaker forecasted revenue to fall 4% to 6% sequentially. Gross margin is also expected to fall within the range of 18% to 20%, compared to 22.5% in the first quarter.
Still, the first quarter saw SMIC’s wafer shipments increase by 15% from the previous quarter and by about 28% year-on-year.
In the earnings call, SMIC attributed that growth to customer shipment pull in, brought by changes in geopolitics and increased demand driven by government policies such as domestic trade-in programs and consumption subsidies.
In another positive sign for the company, its first-quarter capacity utilization— the percentage of total available manufacturing capacity that is being used at any given time— reached 89.6%, up 4.1% quarter on quarter.
“SMIC’s nearly 90% utilization rate reflects strong domestic demand for semiconductors, likely driven by smartphone and consumer electronics production,” said Ray Wang, a Washington-based semiconductor and technology analyst, adding that the demand was also reflected in the company’s strong quarterly revenue growth.
Meanwhile, the company said in the earnings call that it is “currently in an important period of capacity construction, roll out, and continuously increasing market share.”
However, SMIC’s first-quarter research and development spending decreased to $148.9 million, down from $217 million in the previous quarter.
Amid increased demand, it will be crucial for SMIC to continue ramping up their capacity, Simon Chen, principal analyst of semiconductor manufacturing at Informa Tech told CNBC.
SMIC generates most of its revenue from older-generation semiconductors, often referred to as “mature-node” or “legacy” chips, which are commonly found in consumer electronics and industrial equipment.
The state-backed chipmaker is critical to Beijing’s ambitions to build a self-sufficient semiconductor supply chain, with the government pumping billions into such efforts. Over 84% of its first-quarter revenue was derived from customers in China.
“The localization transformation of the supply chain has been strengthened, and more manufacturing demand has shifted back domestically,” a representative said Friday.
However, chip analysts say the chipmaker’s ability to increase capacity in advance chips — used in applications that demand higher levels of computing performance and efficiency at higher yields — is limited.
This is due to U.S.-led export controls, which prevent it from accessing some of the world’s most advanced chip-making equipment from the Netherlands-based ASML.
Nevertheless, the chipmaker appears to be making some breakthroughs. Advanced chips manufactured by SMIC have reportedly appeared in various Huawei products, notably in the Mate 60 Pro smartphone and some AI processors.
In the earnings call, the company also said it would closely monitor the potential impacts of the U.S.-China trade war on its demand, noting a lack of visibility for the second half of the year.
Phelix Lee, an equity analyst for Morningstar focused on semiconductors, told CNBC that the impacts of U.S. tariffs on SMIC are limited due to most of its revenue coming from Chinese customers.
While U.S. customers make up about 8-15% of revenue on a quarterly basis, the chips usually remain and are consumed in Chinese products and end users, he said.
“There could be some disruption to chemical, gas, and equipment supply; but the firm is working on alternatives in China and other non-U.S. regions,” he added.
SMIC’s Hong Kong-listed shares have gained over 32.23% year-to-date.
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.
Smith Collection | Gado | Getty Images
Amazon is expanding its online pharmacy to fill prescription pet medications, the company announced Thursday.
The company said it has added “hundreds of commonly prescribed pet medications” to its U.S. site, ranging from flea and tick solutions to treatments for chronic conditions.
Prescriptions are purchased via Amazon’s storefront and must be approved by a veterinarian. Online pet pharmacy Vetsource will oversee the dispensing and delivery of medications, said Amazon, adding that items are typically delivered within two to six days.
Amazon launched its digital drugstore in 2020 with the added perk of discounts and free delivery for Prime members. The company has been working to speed up prescription shipments over the past year, bringing same-day delivery to a handful of U.S. cities. Last October, Amazon set a goal to make speedy medicine delivery available in nearly half of the U.S. in 2025.
The new pet medication offerings puts Amazon into more direct competition with online pet pharmacy Chewy, as well as Walmart, which offers pet prescription delivery.
Amazon Pharmacy is part of the company’s growing stable of healthcare offerings, which also includes One Medical, the primary care provider it acquired for roughly $3.9 billion in July 2022. Amazon’s online pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack.
Coinbase agreed to acquire Dubai-based Deribit, a major crypto derivatives exchange, for $2.9 billion, the largest deal in the crypto industry to date.
The company said Thursday that the cost comprises $700 million in cash and 11 million shares of Coinbase class A common stock. The transaction is expected to close by the end of the year.
Shares of Coinbase rose nearly 6%.
The acquisition positions Coinbase as an international leader in crypto derivatives by open interest and options volume, Greg Tusar, vice president of institutional product, said in a blog post – which could allow it take on big players like Binance. Coinbase operates the largest marketplace for buying and selling cryptocurrencies within the U.S., but has a smaller share of the global crypto market, where activity largely takes place on Binance.
Deribit facilitated more than $1 trillion in trading volume last year and has about $30 billion of current open interest on the platform.
“We’re excited to join forces with Coinbase to power a new era in global crypto derivatives,” Deribit CEO Luuk Strijers said in a statement. “As the leading crypto options platform, we’ve built a strong, profitable business, and this acquisition will accelerate the foundation we laid while providing traders with even more opportunities across spot, futures, perpetuals, and options – all under one trusted brand. Together with Coinbase, we’re set to shape the future of the global crypto derivatives market.”
Tusar also noted that Deribit has a “consistent track record” of generating positive adjusted EBITDA the company believes will grow as a combined entity.
“One of the things we liked most about this deal is that it’s not just a game changer for our international expansion plans — it immediately diversifies our revenue and enhances profitability,” Tusar told CNBC.
The deal comes at a time when the crypto industry is riding regulatory tailwinds from the first ever pro-crypto White House. Support of the industry has fueled crypto M&A activity in recent weeks. In March, crypto exchange Kraken agreed to acquire NinjaTrader for $1.5 billion, and last month Ripple agreed to buy prime broker Hidden Road.
Don’t miss these cryptocurrency insights from CNBC Pro: